Kramer Robin bought BIIB

February 16, 2024 · Form 4 insider transaction

Kramer Robin bought 914 shares of Biogen Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.

Direction

Acquired (buy-side)

914

Price

$0.00

Total value

N/A

InsiderKramer Robin

Role—

CompanyBiogen Inc. (BIIB)

SecurityCommon Stock

Transaction codeM: Option exercise

Transaction dateFebruary 16, 2024

Filing dateFebruary 21, 2024

Shares owned after6,192

OwnershipDirect

10b5-1 planNo

AmendedNo

View the original Form 4 on SEC EDGAR